Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia

Jun LI; Su-Yu ZONG; Zi-Xi YIN; Yang-Yang GAO; Li-Peng LIU; Yang WAN; Yang LAN; Xiao-Wen GONG; Xiao-Fan ZHU.
Chinese Journal of Contemporary Pediatrics ; (12): 303-308, 2022.
Artículo en Inglés | WPRIM | ID: wpr-928604

Documentos relacionados

  1. Significance of paroxysmal nocturnal hemoglobinuria clone in immunosuppressive therapy for children with severe aplastic anemia.
  2. Concomitant Immunosuppressive Therapy and Eculizumab Use in Patients with Paroxysmal Nocturnal Hemoglobinuria: An International PNH Registry Analysis.
  3. Rare germline complement factor H variants in patients with paroxysmal nocturnal hemoglobinuria.
  4. [The variation and clinical significance of paroxysmal nocturnal hemoglobinuria clone in patients with aplastic anemia before and after immunosuppressive therapy].
  5. Pathophysiology, diagnosis, and treatment of paroxysmal nocturnal hemoglobinuria: a review.
  6. Paroxysmal nocturnal haemoglobinuria (PNH): novel therapies for an ancient disease.
  7. Clinical features and survival of asian pediatric patients with paroxysmal nocturnal hemoglobinuria: results from a single center in China.
  8. Update on paroxysmal nocturnal haemoglobinuria: on the long way to understand the principles of the disease.
  9. Development of clinical paroxysmal nocturnal haemoglobinuria in children with aplastic anaemia.
  10. Gene targeting as a therapeutic avenue in diseases mediated by the complement alternative pathway.